Abstract
Multitarget drugs are a family of compounds that are designed—either deliberately or by accident—to have a nonselective profile toward biological targets. Totally novel treatment options have emerged from this approach, and in some cases it has brought relief to millions of people in global regions that have suboptimal access to proper medicines. Repositioning of existing drugs for novel indications is therefore considered a valid and welcome strategy that has found support from governmental and nonprofit organizations with the aim of positively impacting the lives of patients in need.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
